PERFECT MEDICAL INDUSTRY CO., LTD. Financials Perfect Medical Industry Co., Ltd.
Equities
6543
TW0006543002
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.7 TWD | 0.00% |
|
+1.14% | -4.07% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 717.8 | 1,103 | 771.9 | 744.3 | 842.5 |
| Enterprise Value (EV) 1 | 706.3 | 1,161 | 973.3 | 858.4 | 870.6 |
| P/E ratio | 19.5 x | 11.4 x | 19.9 x | 50.9 x | 21.2 x |
| Yield | 3.82% | 5.33% | 1.66% | 2.27% | 3.79% |
| Capitalization / Revenue | 1.06 x | 1.37 x | 1.07 x | 1.1 x | 1.15 x |
| EV / Revenue | 1.05 x | 1.44 x | 1.34 x | 1.27 x | 1.19 x |
| EV / EBITDA | 8.6 x | 7.05 x | 9.68 x | 16.7 x | 8.06 x |
| EV / FCF | 16.6 x | -78.9 x | -9.34 x | 25.3 x | 12.3 x |
| FCF Yield | 6.04% | -1.27% | -10.7% | 3.96% | 8.16% |
| Price to Book | 1.39 x | 1.9 x | 1.4 x | 1.15 x | 1.27 x |
| Nbr of stocks (in thousands) | 40,458 | 40,458 | 40,458 | 45,663 | 45,663 |
| Reference price 2 | 17.74 | 27.26 | 19.08 | 16.30 | 18.45 |
| Announcement Date | 07/04/20 | 29/03/21 | 18/03/22 | 28/03/23 | 20/03/24 |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 572.8 | 675.7 | 807.8 | 724.6 | 677 | 734.1 |
| EBITDA 1 | 73.72 | 82.1 | 164.6 | 100.5 | 51.54 | 108 |
| EBIT 1 | 45.68 | 50.4 | 129.7 | 58.24 | 3.651 | 58.36 |
| Operating Margin | 7.98% | 7.46% | 16.06% | 8.04% | 0.54% | 7.95% |
| Earnings before Tax (EBT) 1 | 50.4 | 49.86 | 133.4 | 62.52 | 17.98 | 54.25 |
| Net income 1 | 37.36 | 36.44 | 100.7 | 38.77 | 14.27 | 40.09 |
| Net margin | 6.52% | 5.39% | 12.47% | 5.35% | 2.11% | 5.46% |
| EPS 2 | 1.052 | 0.9103 | 2.402 | 0.9582 | 0.3200 | 0.8700 |
| Free Cash Flow 1 | -12.11 | 42.63 | -14.71 | -104.2 | 33.96 | 71.03 |
| FCF margin | -2.11% | 6.31% | -1.82% | -14.38% | 5.02% | 9.67% |
| FCF Conversion (EBITDA) | - | 51.92% | - | - | 65.89% | 65.77% |
| FCF Conversion (Net income) | - | 116.97% | - | - | 237.96% | 177.17% |
| Dividend per Share 2 | 0.6779 | 0.6779 | 1.453 | 0.3159 | 0.3700 | 0.7000 |
| Announcement Date | 14/03/19 | 07/04/20 | 29/03/21 | 18/03/22 | 28/03/23 | 20/03/24 |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.4 | - | 58 | 201 | 114 | 28.1 |
| Net Cash position 1 | - | 11.4 | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.005439 x | - | 0.3524 x | 2.004 x | 2.213 x | 0.2604 x |
| Free Cash Flow 1 | -12.1 | 42.6 | -14.7 | -104 | 34 | 71 |
| ROE (net income / shareholders' equity) | 8.71% | 7.63% | 18.4% | 6.7% | 2.32% | 6.1% |
| ROA (Net income/ Total Assets) | 5.12% | 5.07% | 10% | 3.68% | 0.23% | 3.75% |
| Assets 1 | 730 | 719 | 1,005 | 1,052 | 6,234 | 1,069 |
| Book Value Per Share 2 | 12.40 | 12.80 | 14.30 | 13.60 | 14.20 | 14.50 |
| Cash Flow per Share 2 | 1.000 | 1.690 | 2.350 | 2.800 | 2.030 | 3.530 |
| Capex 1 | 41.3 | 49.2 | 122 | 103 | 52.7 | 64.7 |
| Capex / Sales | 7.2% | 7.28% | 15.12% | 14.26% | 7.79% | 8.81% |
| Announcement Date | 14/03/19 | 07/04/20 | 29/03/21 | 18/03/22 | 28/03/23 | 20/03/24 |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -4.07% | 2.51Cr | |
| +10.10% | 2.78TCr | |
| -30.75% | 308.75Cr | |
| +35.19% | 265.77Cr | |
| -18.85% | 244.43Cr | |
| +6.85% | 223.92Cr | |
| +33.33% | 205Cr | |
| -4.71% | 201.7Cr | |
| +34.05% | 134.99Cr | |
| +3.25% | 133.01Cr |
- Stock Market
- Equities
- 6543 Stock
- Financials Perfect Medical Industry Co., Ltd.
